Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Thomsen

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 14, 2022
Long-term changes in coronary physiology after aortic valve replacementMuhammad Sabbah, Niels T Olsen, Lene Holmvang, et al.
Oncotarget|September 5, 2015
PAPP-A proteolytic activity enhances IGF bioactivity in ascites from women with ovarian carcinomaJacob Thomsen, Rikke Hjortebjerg, Ulrick Espelund, et al.
American Heart Journal Plus : Cardiology Research and Practice|October 16, 2025
Prognostic impact of cardiac dysfunctions in patients with ST-segment elevation myocardial infarctionYan Zhou, Jasmine Melissa Marquard, Lars Nepper Christensen, et al.
European Heart Journal. Cardiovascular Imaging|February 15, 2014
Takotsubo cardiomyopathy, a two-stage recovery of left ventricular systolic and diastolic function as determined by cardiac magnetic resonance imagingKiril Aleksov Ahtarovski, Kasper Karmark Iversen, Thomas Emil Christensen, et al.
American Heart Journal|May 6, 2021
Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarctionJasmine Melissa Madsen, Mia Ravn Jacobsen, Muhammad Sabbah, et al.
European Heart Journal. Cardiovascular Imaging|January 6, 2026
Ten-year prognostic impact of cardiac magnetic resonance endpoints in patients with ST-segment elevation myocardial infarctionBen Elezi, Jasmine Melissa Marquard, Henning Kelbæk, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 16, 2016
Subacute cardiac rubidium-82 positron emission tomography (<sup>82</sup>Rb-PET) to assess myocardial area at risk, final infarct size, and myocardial salvage after STEMIAdam Ali Ghotbi, Andreas Kjaer, Lars Nepper-Christensen, et al.
European Heart Journal. Cardiovascular Imaging|June 15, 2012
Left atrial volume and function in patients following ST elevation myocardial infarction and the association with clinical outcome: a cardiovascular magnetic resonance studyJacob Thomsen Lønborg, Thomas Engstrøm, Jacob Eifer Møller, et al.
Trials|November 6, 2024
Interleukin-6 receptor antibodies (tocilizumab) in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (DOBERMANN-T): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trialJoakim Bo Kunkel, Sarah Louise Duus Holle, Christian Hassager, et al.
Trials|October 31, 2024
Low-dose dobutamine in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (the DOBERMANN-D trial): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trialSarah Louise Duus Holle, Joakim Bo Kunkel, Christian Hassager, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 14, 2022
Long-term changes in coronary physiology after aortic valve replacementMuhammad Sabbah, Niels T Olsen, Lene Holmvang, et al.
Oncotarget|September 5, 2015
PAPP-A proteolytic activity enhances IGF bioactivity in ascites from women with ovarian carcinomaJacob Thomsen, Rikke Hjortebjerg, Ulrick Espelund, et al.
American Heart Journal Plus : Cardiology Research and Practice|October 16, 2025
Prognostic impact of cardiac dysfunctions in patients with ST-segment elevation myocardial infarctionYan Zhou, Jasmine Melissa Marquard, Lars Nepper Christensen, et al.
European Heart Journal. Cardiovascular Imaging|February 15, 2014
Takotsubo cardiomyopathy, a two-stage recovery of left ventricular systolic and diastolic function as determined by cardiac magnetic resonance imagingKiril Aleksov Ahtarovski, Kasper Karmark Iversen, Thomas Emil Christensen, et al.
American Heart Journal|May 6, 2021
Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarctionJasmine Melissa Madsen, Mia Ravn Jacobsen, Muhammad Sabbah, et al.
European Heart Journal. Cardiovascular Imaging|January 6, 2026
Ten-year prognostic impact of cardiac magnetic resonance endpoints in patients with ST-segment elevation myocardial infarctionBen Elezi, Jasmine Melissa Marquard, Henning Kelbæk, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 16, 2016
Subacute cardiac rubidium-82 positron emission tomography (<sup>82</sup>Rb-PET) to assess myocardial area at risk, final infarct size, and myocardial salvage after STEMIAdam Ali Ghotbi, Andreas Kjaer, Lars Nepper-Christensen, et al.
European Heart Journal. Cardiovascular Imaging|June 15, 2012
Left atrial volume and function in patients following ST elevation myocardial infarction and the association with clinical outcome: a cardiovascular magnetic resonance studyJacob Thomsen Lønborg, Thomas Engstrøm, Jacob Eifer Møller, et al.
Trials|November 6, 2024
Interleukin-6 receptor antibodies (tocilizumab) in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (DOBERMANN-T): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trialJoakim Bo Kunkel, Sarah Louise Duus Holle, Christian Hassager, et al.
Trials|October 31, 2024
Low-dose dobutamine in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (the DOBERMANN-D trial): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trialSarah Louise Duus Holle, Joakim Bo Kunkel, Christian Hassager, et al.
Pageof 3